[1] |
WU Fan, FU Linjie, ZHU He, XU Mengyan.
Signal detection of adverse reaction of endothelin receptor antagonists based on FAERS and JADER database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1056-1063.
|
[2] |
ZHAO Jie, GAO Ming'e, CHANG Hong, FAN Huixia.
Two cases of allergic reactions in children caused by compound polyethylene glycol electrolyte powder
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 816-818.
|
[3] |
CHEN Jie, ZHANG Bin, ZHAO Jun, ZHANG Chuanzhou.
One case of allergic shock caused by tocilizumab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 349-351.
|
[4] |
JIANG Nan, WANG Kun, ZHANG Gangping, XING Ruimin, WANG Haiye.
One Case of Anaphylaxis Caused by Magnesium Isoglycyrrhizinate Injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1309-1311.
|
[5] |
LIU Meng, FANG Ke, YAN Jiaju, LIU Meng, HE Manyun, WEI Liangbing.
One case of anaphylactic shock caused by pamidronate disodium glucose injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1172-1174.
|
[6] |
JIANG Renjun, QIN Shuyong, WANG Yuan, LUO Sui.
One case of severe allergic shock caused by misoprostol tablets
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1175-1177.
|
[7] |
MENG Kangkang, LIU Saiyue.
After-marketing safety of coenzyme Q10 for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 795-798.
|
[8] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[9] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|
[10] |
WEI Anhua, QI Jianjun, WANG Lu, ZENG Lu, GONG Xuepeng, JIANG Ying.
Adverse drug reaction/ event caused by oral antidiabetic drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1415-1420.
|
[11] |
PENG Jing, TUO Yali, LI Qiaoling, ZHOU Rong, LI Xinlin, PENG Hui.
Data analysis of adverse events of clobazam among children based on foreign pharmacovigilance safety spontaneous reporting system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1264-1268.
|
[12] |
TANG Yan, WANG Jialin, ZHOU Jingya, ZHAO Weigang, DU Boran, HU Dandan, YANG Liping, YANG Yingying, ZHAO Zhe, YUAN Tao.
Pharmaceutical care for a case of fulminant type 1 diabetes with insulin allergy and positive insulin autoantibodies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1376-1379.
|
[13] |
WU Yingqi, ZHU Ting, TONG Tong, LI Min, SHEN Aizong.
Factors related to ADR/ADE of albumin bound paclitaxel
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1123-1127.
|
[14] |
MA Xue, QI Tingting, YU Wentao.
Pharmaceutical Care of a Patient Suspected to Be Allergic to Meropenem and Treated with Imipenem/Cisstatine Sodium
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 887-889.
|
[15] |
WANG Chunting, MA Minkang, ZHENG Mingjie.
Safety Risks of Somatostatin for Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1080-1082.
|